In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux

Journal of Lipid Research

Volumn 45, Issue 2, 2004, Pages 337-346

  Yancey, Patricia G ^a   Kawashiri, Masa Aki ^b   Moore, Ryan ^b   Glick, Jane M ^b   Williams, David L ^c   Connelly, Margery A ^c   Rader, Daniel J ^b   Rothblat, George H ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

ATP binding cassette transporter 1; High density lipoprotein; Scavenger receptor BI

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPASE; SCAVENGER RECEPTOR; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE; CHOLESTEROL; CRICETINAE; FEMALE; HUMANS; LIPASE; LIPOLYSIS; LIPOPROTEINS, HDL; MICE; MICE, TRANSGENIC; PHOSPHOLIPASES; PHOSPHOLIPIDS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 1242297079     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300231-JLR200     Document Type: Article

References (49)

1. Badimon, J. J., V. Fuster, and L. Badimon. 1992. Role of high density lipoproteins in the regression of atherosclerosis. Circulation. 86: 86-94.
2. Barrer, P. J., and K-A. Rye. 1996. High density lipoproteins and coronary heart disease. Atherosclerosis. 121: 1-12.
3. Schaefer, E. J., S. Lamon-Fava, J. M. Ordovas, S. D. Cohn, M. M. Schaefer, W. P. Castelli, and P. W. F. Wilson. 1994. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J. Lipid Res. 35: 871-882.
4. Stein, O., and Y. Stein. 1999. Atheroprotective mechanisms of HDL. Atherosclerosis. 144: 285-301.
5. Glomset, J. A., and J. L. Wright. 1964. Some properties of a cholesterol esterifying enzyme in human plasma. Biochim. Biophys. Acta. 89: 266-276.
6. Fielding, C. J. 1991. Reverse cholesterol transport. Curr. Opin. Lipidol. 2: 376-378.
7. Franceschini, G., P. Maderna, and C. R. Sirtori. 1991. Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis. 88: 99-107.
8. Phillips, M. C., W. J. Johnson, and G. H. Rothblat. 1987. Mechanism and consequence of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
9. Jian, B., M. de la Lleva Moya, Y. Ji, N. Wang, M. C. Phillips, J. B. Swaney, A. R. Tall, and G. H. Rothblat. 1998. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J. Biol. Chem. 273: 5599-5606.
10. de la Llera-Moya, M., G. H. Rothblat, M. A. Connelly, G. Kellner-Weibel, S. W. Sakr, M. C. Phillips, and D. L. Williams. 1999. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J. Lipid Res. 40: 575-580.
11. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
12. Brousseau, M. E., G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman. 2000. Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J. Lipid Res. 41: 1125-1135.
13. Oram, J. F. 2001. Tangier disease and ABCA1. Biochim. Biophys. Acta. 1529: 321-330.
14. Ji, Y., B. Jian, N. Wang, Y. Sun, M. de la Llera Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor B1 promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
15. Murao, K., V. Terpstra, S. R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger. 1997. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272: 17551-17557.
16. van Dam, M. J., E. de Groot, S. M. Clee, G. K. Hovingh, A. Brooks-Wilson, A. H. Zwinderman, A. J. Smit, A. H. M. Smelt, A. K. Groen, M. R. Hayden, and J. J. P. Kastelein. 2002. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet. 359: 37-41.
17. Atger, V., M. de la Llera Moya, M. Bamberger, O. Francone, P. Cosgrove, A. Tall, A. Walsh, N. Moatti, and G. Rothblat. 1995. Cholesterol efflux potential of sera from mice expressing human CETP and/or human apolipoprotein AI. J. Clin. Invest. 96: 2613-2622.
18. Fournier, N., M. de la Llera Moya, B. Burkey, J. Swaney, J. Paterniti, Jr., N. Moatti, V. Atger, and G. H. Rothblat. 1996. The role of HDL phospholipids in efflux of cell cholesterol to whole serum: studies with human apo AI transgenic rats. J. Lipid Res. 37: 1704-1711.
19. Kunz, F., C. Pechlaner, R. Erhart, F. Fend, and V. Muhlberger. 1994. HDL and plasma phospholipids in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 14: 1146-1150.
20. Jaye, M., K. J. Lynch, T. Krawiec, D. Marchadier, C. Maugeais, K. Doan, V. South, D. Amin, M. Perrone, and D. J. Rader. 1999. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21: 424-428.
21. McCoy, M. G., G-S. Sun, D. Marchadier, C. Maugeais, J. M. Glick, and D. J. Rader. 2002. Characterization of the lipolytic activity of endothelial lipase. J. Lipid Res. 43: 921-929.
22. Walsh, A., Y. Ito, and J. L. Breslow. 1989. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3. J. Biol. Chem. 264: 6488-6494.
23. Kozarsky, K., M. Grossman, and J. M. Wilson. 1993. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somat. Cell Mol. Genet. 19: 449-458.
24. Tsukamoto, K., P. Smith, J. M. Glick, and D. J. Rader. 1997. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J. Clin. Invest. 100: 107-114.
25. Gerdes, L. U., C. Gerdes, I. C. Klausen, and O. Faergeman. 1992. Generation of analytic plasma lipoprotein profiles using two prepacked Superose 6B columns. Clin. Chim. Acta. 205: 1-9.
26. Kellner-Weibel, G., M. de la Llera-Moya, M. A. Connelly, G. Stoudt, A. E. Christian, M. P. Haynes, D. L. Williams, and G. H. Rothblat. 2000. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry. 39: 221-229.
27. Yancey, P. G., M. de la Llera-Moya, S. Swarnakar, P. Monzo, S. M. Klein, M. A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat. 2000. HDL phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor-BI (SR-BI). J. Biol. Chem. 275: 36596-36604.
28. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ABC1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640.
29. Hara, H., A. Komaba, and S. Yokoyama. 1992. α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 27: 302-304.
30. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491.
31. Wang, N., D. Silver, P. Costet, and A. R. Tall. 2000. Specific binding of apoA-I enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275: 33053-33058.
32. de la Llera Moya, M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. H. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relationships between serum components and efflux, esterification and transfer. Arterioscler. Thromb. 14: 1056-1065.
33. Fournier, N., J. L. Paul, V. Atger, M. de la Llera Moya, G. Rothblat, and N. Moatti. 1997. HDL phospholipid content and composition as a major determinant of cholesterol efflux to whole serum. Arterioscler. Thromb. Vase. Biol. 17: 2685-2691.
34. Davidson, W. S., W. V. Rodrigueza, S. Lund-Katz, W. J. Johnson, G. H. Rothblat, and M. C. Phillips. 1995. Effects of acceptor particle size on the efflux of cellular free cholesterol. J. Biol. Chem. 270: 17106-17113.
35. Rye, K. A., and M. N. Duong. 2001. Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins. J. Lipid Res. 41: 1640-1650.
36. Collet, X., A. R. Tall, H. Serajuddin, K. Guendouzi, L. Royer, H. Oliveira, R. Barbaras, X. C. Jiang, and O. L. Francone. 1999. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J. Lipid Res. 40: 1185-1193.
37. Lambert, G., M. B. Chase, K. Dugi, A. Bensadoun, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1999. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J. Lipid Res. 40: 1294-1303.
38. Foger, B., M. Chash, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, H. B. J. Brewer, and S. Santamarina-Fojo. 1999. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274: 36912-36920.
39. Strauss, J. G., R. Zimmermann, A. Hrzenjak, Y. Zhou, D. Kratky, S. Levak-Frank, G. M. Kostner, R. Zechner, and S. Frank. 2002. Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymatic activity. Biochem. J. 368: 69-79.
40. Jin, W., J. S. Millar, U. Broedl, J. M. Glick, and D. J. Rader. 2003. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J. Clin. Invest. 111: 357-362.
41. Cohen, J. C. 2003. Endothelial lipase: direct evidence for a role in HDL metabolism. J. Clin. Invest. 106: 318-321.
42. Ishida, T., S. Choi, R. K. Kundu, K. Hirata, E. M. Rubin, A. D. Cooper, and T. Quertermous. 2003. Endothelial lipase is a major determinant of HDL level. J. Clin. Invest. 111: 347-355.
43. Jian, B., M. de la Llera-Moya, L. Royer, G. Rothblat, O. Francone, and J. B. Swaney. 1997. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744.
44. Khoo, J. C., E. M. Mahoney, and J. L. Witztum. 1981. Secretion of lipoprotein lipase by macrophages in culture. J. Biol. Chem. 256: 7105-7108.
45. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum. 1991. Macrophage and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88: 10143-10147.
46. O'Brien, K. D., D. Gordon, S. S. Deeb, M. Ferguson, and A. Chait. 1992. Lipoprotein lipase is s)mthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J. Clin. Invest. 89: 1544-1550.
47. Tabas, I. 1999. Secretory sphingomyelinase. Chem. Phys. Lipids. 102: 123-130.
48. González-Navarro, H., Z. Nong, L. Freeman, A. Bensadoun, K. Peterson, and S. Santamarina-Fojo. 2002. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J. Lipid Res. 43: 671-675.
49. Chen, H. W., and H. C. Huang. 1998. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br. J. Pharmacol. 124: 1029-1040.